NCT06417541

Brief Summary

Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clinical autopsy are included. Before the autopsy, the deceased will be examined with a photon-counting computed tomography (CT) scan and the results will be compared. In sub-study 2, living patients with CVC who are referred for various CT scans without contrast, are included. After informed consent, the patient will be examined with the photon-counting CT, whose reliability has been validated in Part 1 and the incidence of subclinical CVC-related thrombosis will be reported.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
25mo left

Started Jan 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2025Jun 2028

First Submitted

Initial submission to the registry

May 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

January 16, 2025

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

2.4 years

First QC Date

May 11, 2024

Last Update Submit

April 27, 2026

Conditions

Keywords

central venous catheterthrombosisphoton counting ct

Outcome Measures

Primary Outcomes (4)

  • The incidence of venous thrombosis related to a central venous catheter in diseased patients

    Venous thrombosis related to a central venous catheter detected at autopsy

    At autopsy

  • The performance of the photon counting CT on diseased patients

    The performance of the photon counting CT will be evaluated by comparing the findings from the CT with the findings from the autopsy

    After death. The CT scan and the autopsy will be performed within 1 week after death

  • The incidence of venous thrombosis related to a central venous catheter in living patients

    The incidence of venous thrombosis related to a central venous catheter in living patients detected with a photon counting CT

    At CT scan

  • The performance of ultrasound compared to the photon counting CT

    The performance of ultrasound compared to the photon counting CT in detecting enous thrombosis related to central venous catheters

    Ultrasound will be performed ±24 hours from the CT

Study Arms (2)

Diseased patients with an indwelling central venous catheter

Sub study 1, Diseased patients with an indwelling central venous catheter

Diagnostic Test: Diseased patients with an indwelling central venous catheter who is referred to autopsy

Living patients with an indwelling central venous catheter

Living patients with an indwelling central venous catheter who are referred to a CT-scan without intravenous contrast

Radiation: Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast

Interventions

Patients will be investigated using a photon counting CT. Prior to the investigation patients will be investigated with ultrasound. The results from the two modalities will be compared

Living patients with an indwelling central venous catheter

Photon counting CT is performed and the results are compared to the results of the autopsy

Diseased patients with an indwelling central venous catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Substudy 1: Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy Substudy 2: Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast

You may qualify if:

  • Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy
  • Informed and signed consent from next of kind

You may not qualify if:

  • None
  • Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
  • Informed and signed consent from the patient
  • \- GFR \<15 mL/min/1.73 m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensive and Perioperative Care. Skåne University Hospital. Lund

Lund, Skåne County, 22185, Sweden

RECRUITING

Related Publications (3)

  • Forauer AR, Theoharis C. Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1163-8. doi: 10.1097/01.rvi.0000086531.86489.4c.

    PMID: 14514808BACKGROUND
  • Wichmann D, Heinemann A, Zahler S, Vogel H, Hopker W, Puschel K, Kluge S. Prospective study of device-related complications in intensive care unit detected by virtual autopsy. Br J Anaesth. 2018 Jun;120(6):1229-1236. doi: 10.1016/j.bja.2018.02.031. Epub 2018 Apr 4.

    PMID: 29793590BACKGROUND
  • Rockholt MM, Naddi L, Badri AM, Englund E, Kander T. Macro- and microscopic changes in veins with short-term central venous catheters: an observational autopsy study. BMC Anesthesiol. 2024 Jan 2;24(1):5. doi: 10.1186/s12871-023-02380-x.

    PMID: 38166620BACKGROUND

MeSH Terms

Conditions

Upper Extremity Deep Vein ThrombosisThrombosis

Interventions

Contrast Media

Condition Hierarchy (Ancestors)

Venous ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Uses of ChemicalsPharmacologic ActionsChemical Actions and UsesSpecialty Uses of Chemicals

Study Officials

  • Thomas Kander

    Lund University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Thomas Kander, PhD

CONTACT

Emilia Ängeby Eriksson, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor investigator

Study Record Dates

First Submitted

May 11, 2024

First Posted

May 16, 2024

Study Start

January 16, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2028

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Upon reasonable request, de-identified individual participant data from this clinical trial will be shared to facilitate scientific collaboration.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
After the publication of the study up to 3 years after the publication of the study
Access Criteria
Researchers may submit requests through the specified channel, detailing the purpose and proposed analyses. Approved applicants will sign a data access agreement, ensuring responsible and transparent use of the data.

Locations